Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5687464 | The Journal of Urology | 2017 | 31 Pages |
Abstract
The duration from radical prostatectomy to salvage radiotherapy is not independently prognostic for outcomes after salvage radiotherapy and it should not be used to define early salvage radiotherapy. Grouping all patients with pre-salvage radiotherapy prostate specific antigen 0.5 ng/ml or less may be inadequate to define early salvage radiotherapy and it has a relevant impact on ongoing and future clinical trials.
Keywords
ADTPSAPCSSsRTPCSMBRFsDMFSProstate specific antigenBiochemical relapse-free survivalADT, Androgen deprivation therapySalvage therapyRadiotherapyAdjuvant radiotherapySalvage radiotherapyRadical prostatectomydistant metastasis-free survivalProstate cancer specific mortalityProstatic neoplasmsARTprostate-specific antigenProstatectomy
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ahmed Abugharib, William C. Jackson, Vasu Tumati, Robert T. Dess, Jae Y. Lee, Shuang G. Zhao, Moaaz Soliman, Zachary S. Zumsteg, Rohit Mehra, Felix Y. Feng, Todd M. Morgan, Neil Desai, Daniel E. Spratt,